BiotechTube
Home/AvenCell Therapeutics/Susan Buttler
SB

Susan Buttler

VP, Clinical Operations

AvenCell Therapeutics

Therapeutic Areas

Oncology

AvenCell Therapeutics Pipeline

DrugIndicationPhase
Universal Switchable CAR-T ProgramsHard-to-treat cancers (hematological and solid tumors)Phase 1

Leadership Team at AvenCell Therapeutics

AS
Andrew Schiermeier, Ph.D.
Chief Executive Officer
MK
Manfred Klevesath, MD, Ph.D.
Chief Medical Officer
RL
Reynald Lescarbeau, Ph.D.
SVP, Global Research
MC
Marc Cartellieri, Ph.D.
Chief Technology Officer
View full AvenCell Therapeutics profile